Skip to content
Lower risk Drug recall · FDA · Published August 11, 2023

AVKARE Capsaicin Cream 0.025% Recall: Risk of Wrong Product Mix-up

AVKARE recalls Capsaicin Cream 0.025% due to possible mix-up with Sodium Fluoride toothpaste. This could cause dental issues if used incorrectly. Check product labels and contact for details.

🇺🇸 FDA recall #D-1147-2023DrugAVKARE ›
Take action

Contact the company

Recalling firmAVKARE LLC615 N 1st St · Pulaski, TN 38478-2403
✎ GovInfoNow plain-language explainer

AVKARE is recalling Capsaicin Cream 0.025% because cartons labeled as this cream might contain tubes of Sodium Fluoride toothpaste instead. Using the wrong product could cause dental problems if applied to teeth. Read more at govinfonow.com/recall/33211-avkare-capsaicin-cream-0-025-recall-risk-of-wrong-product.

Source Summary by GovInfoNow · govinfonow.com/recall/33211-avkare-capsaicin-cream-0-025-recall-risk-of-wrong-product · Updated August 17, 2026 · FDA enforcement record: FDA #D-1147-2023

Cite this page

“AVKARE Capsaicin Cream 0.025% Recall: Risk of Wrong Product Mix-up.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33211-avkare-capsaicin-cream-0-025-recall-risk-of-wrong-product. Based on FDA recall #D-1147-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1147-2023%22&limit=1).

AVKARE LLC voluntarily recalled Capsaicin Cream 0.025% on August 11, 2023, after cartons labeled as pain relief cream were found to contain prescription dental toothpaste, according to the FDA.

How to tell if you have it

  • Brand: AVKARE
  • Product: Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g)
  • NDC: 50268-195-60
  • Lot #: P22078
  • Expiration: 11/30/2024
  • Quantity: 35,184 cartons

The hazard

The recall addresses a product mix-up where cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show AVKARE LLC has two other recalls on file since December 22, 2022, including a June 13, 2023, recall of Tranexamic Acid Tablets due to impurity issues and a December 22, 2022, recall of Glycopyrrolate Tablets for unknown impurities. Other recent recalls of similar products include Keystone Dental City Topical Anesthetic Gel (May 21, 2026) and Sun Pharmaceutical Fluocinonide Cream (March 25, 2026).

How to tell if you have this one

Check for the product label: Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g). The NDC code is 50268-195-60. The expiration date is 11/30/2024.

  • Brand
    AVKARE
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Affected product was distributed to nineteen (19) consignees within the united states.
Recall numberProduct, codes & lotsQuantityNDC
D-1146-2023Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 ppm Fluoride Plus Mild Cleaning System Spearmint NET WT. 1.8 OZ. (51g), Rx only, NDC 42291-741-51, Manufactured for: AvKARE Pulaski, TN 38478; Lot # P23025 Exp. 02/24/202535,184 tubes42291-741-51
D-1147-2023Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDC 50268-195-60, Manufactured for: AvKARE, Pulaski, TN 38478; Lot # P22078; Exp. 11/30/202435,184 cartons50268-195-60
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the label: Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g).

How this recall unfolded

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Aug 11, 202312. FDA classified it Class II: Sep 7, 202323. Published in FDA’s Enforcement Report: Sep 13, 202334. FDA terminated the recall: Apr 29, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1147-2023 (August 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1147-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA